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INTRODUCTION 
Worldwide there has been an increase in the prevalence of overweight and obese women 
in the reproductive age group. Since the rate of both maternal and fetal complications are 
higher in this category, it is very important for the health professionals to be aware of the 
associated complications to tailor the antenatal care according to the need for this 
population. 
This study looks at the rate of gestational hypertension in the two groups of BMI – 
normal 18.5-24.99 kg/m2 and BMI >35 kg/m2 in women who had primary LSCS. This 
gives us an idea if gestational hypertension which is not a cause of major morbidity or 
mortality has been contributory in raising the rate of primary caesarean section especially 
in the group of BMI >35 kg/m2. The study also compares the maternal and the fetal 
outcomes in the 2 BMI groups which gives association of BMI >35 kg/m2 and increase 
in complications as compared to those with normal BMI. 
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AIM 
 
To compare the rate of gestational hypertension in obese women with BMI >35kg/m2 
who had primary caesarean section with women who have normal BMI who had primary 
caesarean section. 
 
 
OBJECTIVES 
 
1. To prove that obese women with BMI >35 kg/m2 who had primary caesarean 
section have higher rate of gestational hypertension when compared to women 
with normal BMI who had primary caesarean section. 
2. To compare the maternal and fetal outcomes in obese women with BMI >35 
kg/m2 who had primary caesarean and women with normal BMI who had primary 
caesarean. 
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REVIEW OF LITERATURE 
 
DEFINITION OF OBESITY:  
Obesity is a medical condition where excessive fat has accumulated in the body and 
causes increased health risks. 
The word origin is from the latin word obesus, ob- intensive and edere - to eat. 
Historical terms used to define obesity are: stout, corpulent, monstrous, hyperobese, 
massively obese etc. 
Obesity was initially recognized as a disease by WHO in 1948 at the time of its formation 
(1). Since then various measures have been taken to measure body fat, of which most 
accepted is BMI or Body Mass Index. Scott and Law introduced the term „morbid obesity 
in 1970.The international classification of diseases(ICD) subsequently introduced the 
term for coding in 1995.  
It is historically called the disease of industrialized countries. There is rising prevalence 
of obesity worldwide. Across the world it has become the leading cause of morbidity and 
mortality (2)(3). 
 
THE EPIDEMIC OF OBESITY:  
According to the 2011 WHO data there is a significant variation across the globe among 
the prevalence of obese and overweight women with prevalence of obesity among 
women ≥ 15 years between 3.7-93%  across different areas. In America the prevalence of 
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overweight is 62% and obese is 26%  among men and women as compared to south east 
Asia where it is 14% overweight and 3% of obese.  Prevalence of obesity by country and 
WHO world region is tabulated in table-1. 
The following picture shows global prevalence of overweight and obese in 
females≥15yrs,2010 WHO estimates: 
 
 
As in the adult population the rate of childhood obesity also has drastically increased in 
high income countries. Although WHO recognized obesity as a disease, it is considered 
as a health problem of the developed countries with the focus of the low income countries 
being under nutrition and infectious diseases. 
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IMPACT OF OBESITY EPIDEMIC ON HEALTH ECONOMICS: 
Being overweight and obese is associated with multiple co morbidities which increase the 
cost of health care in this population. 45% of the health cost of diabetes and 25% of 
ischemic heart disease is associated with obesity. About 10% of cancer has been 
associated with obesity. Obesity and overweight increases the cost of health care by 
increasing the risk for IHD, diabetes, hypertension, stroke, thromboembolism, 
dyslipidemia. It also increases the cost of reproductive health care by increasing rates of 
infertility, artificial reproductive techniques, abortions, delivery associated problems. 
The health care costs are increased both direct and indirect ways. 
 
Direct costs of obesity are increased by : 
Medication 
Admission to hospital 
Rehabilitation 
Cost of health care workers 
 
Indirect costs of obesity are increased by: 
Loss of work 
Decreased productivity 
Disease and disability 
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A 2010 estimate for United Kingdom showed the cost of treating obesity to be £9.4 
million annually and cost of treating comorbidities to be £470 million annually. These 
have been predicted to be doubling each year which will present 18% of total health 
expenses by 2030 (4)(5).  
ANTHROPOMETRIC MEASUREMENTS:  
The various anthropometric measurements which quantify the nutritional status are : 
1. Height 
2. Weight 
3. Mid arm circumference 
4. Skin fold thickness 
5. BMI 
6. Body build index 
7. Body adiposity index 
8. Sagittal abdominal diameter 
9. Waist-to-hip ratio 
10. Waist to height ratio 
11. Body fat percentage 
12. Body volume index 
These measurements are used to indicate the nutritional status. They are easily applicable 
and enable assessment. 
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Mid Upper Arm circumference: is a simple way for assessment ofnutrition. Values for 
cut off are not established and it varies according to ethnicity. Its been used as indicator 
of undernourished women, but the use of MUAC as an indicator in measuring obesity 
needs further studies. Studies have shown that weight < 50 kgs, height  <145 cms and 
MUAC less than 22 cms need referral for specialized care.(6) 
 
Skin fold thickness measurement-SFTM : can be measured using Harpenden callipers 
and body fat percentage calculated by 
BF% = 12.7 + 0.457 x triceps SFTM + 0.352 x sub scapular SFTM +  0.103 x biceps 
SFTM  – 0.057 x Height + 0.265 x MUAC 
Studies have shown that STFM can be used as  measure of obesity in pregnancy (7)using 
international standards for anthropometry(8) 
 
BMI (Body Mass Index): Adolphe Quetlet developed the Quetlet index in 1832  which 
was termed Body Mass Index by Ancel Keys in 1972. The classification of BMI is based 
on risk of cardiovascular disease. Its defined as weight in Kg divided by height in meters 
squares (9).  
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Classification of  BMI(kg/m2) 
 Principal cut-off points  cut off points-additional 
Underweight <18.5 
 
<18.5 
 
Severe Thinness <16.0 <16.0 
Moderate Thinness 16.0 -16.99 
 
16.0 -16.99 
Mild Thinness 17.0 -18.49 17.0 -18.49 
 
Normal range 
18.50-24.99 18.50-22.99 
23.0 -24.99 
Over weight 
 
≥25.0 
 
 
≥25.0 
 
 Pre-Obese  
25.00-29.99 
25.00-27.49 
27.50-29.99 
Obese ≥30.00 ≥30.00 
Obese Class I 30.00-34.99 30.00-32.49 
32.5-34.99 
Obese Class II 35.00-39.99 35.00-37.49 
37.50-39.99 
Obese Class III ≥40.00 ≥40.00 
 
Body build index or Pignet index was given by Maurice Charles Joseph Pignet and is 
calculated by Ht in cm – Wt in kg + chest circumference in cms. Classification is given 
below: 
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Body build index 
Very sturdy <10 
Sturdy 10-15 
Good 16-20 
Average 21-25 
Weak 26-30 
Very weak 31-35 
Poor >36 
 
Body adiposity index: It measures the body fat without using the weight and is 
calculated by :100 x hip circumference in meters /Ht in meters x height   -18 
 
Sagittalabdominal diameter or SAD: measures visceral obesity measured from the 
narrowest point between last rib and iliac crests to midpoint of iliac crests.  Its not a 
useful tool in pregnancy. 
 
Waist to hip ratio: is measured at midpoint between lower margin of last rib and  top of 
iliac crest. Women with WHR more than 0.8 are at increased health risks. Studies show 
that distribution of fat if central is an independent risk factor for glucose intolerance (10). 
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Waist to height ratio or WHtR: is calculated by waist circumference / height. Values 
more than 0.5 is critical and implies increased health risk. It has been studied like BMI as 
a predictor of gestational hypertensionand pre ecclampsia in early pregnancy(11). 
 
Waist circumference: is measured by placing the measuring tape in horizontal plane 
around the abdomen at the level of iliac crest. The tape shouldnot compress the skin, 
should be parallel to the ground and measured at the end of normal expiration. 
Ethnic group Waist circumference(as measure of 
central obesity) 
Europids 
Men ≥ 94 cm 
Women ≥ 80 cm 
South Asians 
Men ≥ 90 cm 
Women ≥ 80 cm 
Chinese 
Men ≥ 90 cm 
Women ≥ 80 cm 
Japanese 
Men ≥ 94 cm 
Women ≥ 80 cm 
Ethnic South and Central Americans Use South Asian recommendations until 
more specific data are available 
Sub-Saharan Africans Use European data until more specific data 
are available 
Eastern Mediterranean and middle east 
(Arab) populations 
Use European data until more specific data 
are available 
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Body fat percentage: is the total mass of fat divided by the total body mass. Calipers or 
bioelectrical impedance can be used to measure the same. Body fat meter is also used for 
the same. It is a better tool in assessing health risk and shown better correlation as 
predictor of pre ecclampsia.(12) 
  
Body volume index: can be calculated by 3D scanner using Bespoke software. It looks at 
relation of volume distribution and mass.  Its been used as alternative to BMI (13). Not 
yet studied in pregnancy. 
 
INCREASING PREVALENCE OF OBESITY: 
The mean BMI is on a rise all over the world and 0besity is considered as the disease of 
21
st
 century. It has shown a rising trend over the past twenty years and the current 
prevalence ranges between 30-40% in different areas (14)(15)(16)(17). 
 
WHY DIFFERENT CUT OFF FOR ASIANS? 
In Europeans BMI 30 kg/m2 correlates with 30% body fat in females. About for the same 
age and sex African Americans have a lower fat percentage and Asians have higher. Thus 
Asians are at higher health risks of hypertension, diabetes, and heart disease. This 
difference is called Yudkin- Yajnik paradox or the Y-Y paradox. Asian ethnicity is an 
independent variable for determination of visceral obesity(18). Hence the different BMI 
cut off values for asians are different.The cutoffs have been redefined for Asian 
population. The classification is given below: 
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Asian categorization 
Underweight <18.5 kg/m2 
Normal 18.5-23.0kg/m2 
Overweight 23.0-27,5kg/m2 
Obesity ≥27.5 kg/m2 
 
OBESITY IN INDIA:  
Is India gaining weight?  NFHS ( National Family Health Survey ) 2007 shows  11% in 
NFHS-2 which increased to 15 % in NFHS-3  (19).  Still in India undernutrition is a 
greater problem. The problem of overweight and obese is higher in urban areas and is 
probably due to better SES and lesser physical activity.  The percentage of women being 
overweight and obese is highest among Punjab -30%, then Kerala -28% and Delhi 26%  
States Male (%) Male 
Rank 
Female 
(%) 
Female 
Rank 
Punjab 30.3 1 37.5 1 
Kerala 24.3 2 34.0 2 
Goa 20.8 3 27.0 3 
Tamil Nadu 19.8 4 24.4 4 
Andhra Pradesh 17.6 5 22.7 10 
Sikkim 17.3 6 21.0 8 
Mizoram 16.9 7 20.3 17 
Himachal Pradesh 16.0 8 19.5 12 
Maharashtra 15.9 9 18.1 13 
Gujarat 15.4 10 17.7 7 
Haryana 14.4 11 17.6 6 
Karnataka 14.0 12 17.3 9 
Manipur 13.4 13 17.1 11 
India 12.1 14 16.0 15 
Uttarakhand 11.4 15 14.8 14 
Arunachal Pradesh 10.6 16 12.5 19 
Uttar Pradesh 9.9 17 12.0 18 
Jammu and Kashmir 8.7 18 11.1 5 
Bihar 8.5 19 10.5 29 
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Nagaland 8.4 20 10.2 22 
Rajasthan 8.4 21 9.0 20 
Meghalaya 8.2 22 8.9 26 
Orissa 6.9 23 8.6 25 
Assam 6.7 24 7.8 21 
Chattisgarh 6.5 25 7.6 27 
West Bengal 6.1 26 7.1 16 
Madhya Pradesh 5.4 27 6.7 23 
Jharkhand 5.3 28 5.9 28 
Tripura 5.2 29 5.3 24 
 
OBESITY IN PREGNANCY: 
The overweight and the obese women are exposed to risks of abortions, gestational 
diabetes, gestational hypertension, pre ecclampsia, chronic hypertension and fetus is at 
risk of preterm birth,macrosomia, congenital anomalies, still birth, birth injuries, lower 
APGAR scores. These women are also at more risk for caesarean deliveries, wound 
infection, anesthesia related difficulties and complications. Intervention to reduce these 
complications by controlling the pre pregnancy BMI is hence necessary.   
 
ETIOLOGY OF OBESITY: 
The etiology of obesity is multifactorial. There are many cause factor associations about 
pathophysiology, genetics and epigenetics about obesity that is not fully understood. 
There has been change of dietary intake of high calorie food, less physical activity, 
indoor recreational activities like television and computer games which lead to weight 
gain. Evidence shows that in utero environment also has a major role in the development 
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of future obesity. A detailed understanding of these cause effect relationships is required 
to make effective interventions for prevention of obesity. 
 
i 
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Age of onset of obesity: there is no particular age of onset though the major events 
remain puberty, pregnancy and menopause in a women‟s life. 
Weight gain in women starts mostly after the onset of puberty which is increased after the 
weight gain throughout pregnancy and menopause. 
Pregnancy in women causes weight gain and  increase in fat distribution after first 
pregnancy itself which persists and varies depending on factors like race, traditional 
practices and ethnic background (20)(21).  
Menopause: Weight gain and change in fat distribution also occur in early menopausal 
years. Cumulative 6 year change in weight was 2.9 kg and waist circumference was 5.7 
cm(22). 
 
GENETIC FACTORS: 
In relatively fewer number of people, obesity can develop as a consequence of syndromic 
obesity as a consequence of particular genetic defects like in trisomy 21 there is altered 
production of obesity related hormones (23). 
Trisomy Genomic imprinting Monogenic disorders 
Trisomy 21 Prader-Willi Syndrome 
Albright‟s Heriditary Osteodystrophy 
Cohen Syndrome 
Bradet Beidl Syndromes 
Leptin encoding gene 
Leptin receptor gene 
Proopiomelanocortin (24) 
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Better success at understanding associations between obesity and DNA sequence came 
from large population-based genome wide association studies with BMI values. These 
studies have identified more than 30 loci that affect the risk of developing obesity. The 
strongest association has been found between FTO gene on chromosome 16(25), other 
obesity related associations include  TMEM18, KCTD15, GNPDA2,SH2B1,MTCH2 and 
NEGR1which has relationship with hypothalamic function disorders(26). These genetic 
determinants cause weight gain, increase in insulin resistance and early susceptibility to 
developing type 2 DM. The gene polymorphism causes expression through regulation of 
lipid metabolism and thermogenesis(27). 
 
METABOLIC PROGRAMMING: 
The nutritional environment of a developing fetus in utero has shown risk association of 
developing obesity later in life and development of metabolic syndrome related 
comorbidities through the process of metabolic programming(28)(29). Both over 
nutrition and undernourishment have fetal origins of adult onset disease. The relationship 
between in utero overnutrition and neonatal adiposity is well known. The link between 
maternal hyperglycemia and macrosomia was established by Jorgen Pedersenin 1967 
who formulated the Pedersen hypothesis. Further epidemiological studies showed the 
association between not only in utero over nutrition but also pre pregnancy BMI and the 
total weight gained during the pregnancy. The relationship between overeating and 
macrosomia was first proposed by Hugo Ehrenfest in 1919.  A study in the Pima Indians  
showed that children born to women with gestational diabetes were at higher risk of 
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childhood obesity compared to those with normal carbohydrate metabolism. This 
difference persisted after correction of influencing factors (30). Similar findings were 
found among central Mediterranean island children(31) . Further association between 
macrosomia and risk of developing gestational diabetes (32). Islet cell hypertrophy and 
beta cell hyperplasia has been observed in fetuses of diabetic mothers and the degree is 
proportional to BMI and glycemic status. There is malprogramming of orexigenic and 
anorexigenic neurons in hypothalamus mediated through raised levels of fetal and 
neonatal leptin. This causes further predisposition to obesity(33). This confirms 
Pedersen‟s hypothesis. When bottle fed and breast fed children are compared, the bottle 
fed 5 yr old children were more predisposed to obesity. The other extreme being those 
exposed to undernutrition in utero. DJ Barker proposed the relationship between low 
birth weight and childhood obesity and cardiovascular diseases at the age of 50yrs. The 
1944 Dutch famine gave the epidemiological evidence for intrauterine nutritional 
deprivation and intrauterine growth restriction. These individuals with low birth weight 
were at greater predisposition for adult onset chronic diseases(34). The predisposition to 
adiposity is more if the deprivation is during the first half of pregnancy(34). The follow 
up showed that the females exposed to intrauterine starvation had higher BMI than non-
exposed women. There was no significant difference between the famine exposed or non-
exposed men(35). Similar findings were found in central Mediterranean island population 
study. There was childhood obesity at age of 9 years and development of gestational 
diabetes later in life(31)(32). Various epidemiological and animal studies have proven the 
association between antenatal fetal and early postnatal nutrition with insulin resistance 
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and development of obesity and metabolic syndrome later.  The mechanism of metabolic 
programming or developmental plasticity has been directly linked to loss of  pancreatic 
beta cell numbers in fetuses with intrauterine starvation leading to decrease in circulating 
pancreatic insulin concentration and circulating fetal insulin levels (36). Literature also 
supports association between antenatal and early postnatal starvation and methylation of 
cytosine residues and thus causing alteration of genomically imprinted genes like 
IGF2,H19and IGF2R through covalent modifications without changing nucleotide 
sequencing of DNA. These epigenetic changes allow the undernourished fetus to deal 
with future starvation better- the thrifty phenotype hypothesis was coined by Hales and 
Barker in 1992. However in a state of plenty these individuals are at risk of developing 
obesity and type 2 DM when there is state of plenty (37). 
 
 
 
 
 
 
 
 
 
 
 
 
INTRAUTERINE AND 
POSTNATAL 
STARVATION 
THRIFTY 
PHENOTYPE 
OBESITY AND 
METABOLIC 
ABNORMALITIES 
SUBSEQUENT OFFSPRING 
AFFECTED BY PEDERSON’S 
HYPOTHESIS 
ABNORMAL METABOLIC 
PHYSIOLOGY THROUGH 
PEDERSON CYCLE 
25 
 
OBESITY AND INFERTILITY: 
Anovulation explains most of the etiology of infertility and sub-fecundity. This is 
mediated through HPO axis changes, poor oocyte quality and poor endometrial 
receptivity. Poorer reproductive outcomes have been noticed in natural conception as 
well as those by ovulation induction or IVF(38)(39)(40). There is increased aromatization 
of androgens to estrogens and decreased SHBG production in obese women. This caused 
increase in free estradiol and testosterone secretion which is aggravated by hyper 
insulinemiacausing further lower SHBG and stimulates ovarian androgen production. 
This causes increased LH production, increased androgen / estrogen ratio causing 
impaired folliculogenesis and atresia of follicles.Gene expression studies during 
implantation window show endometrial disregulation in women with PCOS (41). 
 
OBESITY AND MISCARRIAGES 
Obesity increases the rate of miscarriage irrespective  whether it is natural or by ART, it 
is increased regardless of PCOS existence (42). The meta analysis by Metwally et al 
shows a n increase in abortion rates in women with BMI > 25 kg/m2(43). Pregnancies 
after oocyte donation, ovulation induction also had higher rates of miscarriage in the 
obese and overweight(44). 
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OBESITY AND ANOMALIES 
The birth defects associated with obesity are summarized in table below. Meta-analysis 
in2008 by Tasmussen et al,2009 by Stothart et al shows increased risk of neural tube 
defects(45) and  congenital heart defects(46),(47). The mechanisms are not established 
but may be associated with undetected diabetes. Obesity is also associated with increased 
follicular fluid insulin levels, triglyceride and lactate levels and C- reactive protein 
levels(41),(48). 
 
Type of birth defect Odds ratio(95% CI) 
Anencephaly 1.39(1.03-1.87) 
Spina bifida 2.24(1.86-2.69) 
Cardiac septal anomalies 1.20(1.09-1.31) 
Tetralogy of Fallot 1.10(0.76-1.61) 
Transportation of the great arteries 1.41(0.97-2.06) 
Cleft lip and palate 1.20(1.03-1.40) 
Diaphragmatic hernia 1.28(0.95-1.71) 
Hydrocephaly 1.68(1.19-2.36) 
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OBESITY AND ULTRASOUND: 
Prenatal ultrasound diagnosis in obese women can be challenging for various reasons. 
There is increased depth of abdominal adipose tissue which makes the visualization 
difficult due to increased depth of insonation (49). The caesarean scar can also affect the 
quality of acoustic window in subsequent pregnancy. The obese women have higher rates 
of twinning with or without infertility treatment which poses another challenge in 
ultrasound diagnosis. FaSTER trial by Thornburg et al found higher failure rates for NT 
screening at first attempt and subsequently also required higher number of attempts in all 
three classes of obesity compared to normal-weight women(50).  The missed diagnosis 
for nuchal fold thickness is 51 % in obese women compared to 39% in normal-weight 
women. Second trimester anomaly scan diagnosis is also difficult due to suboptimal 
visualization in obese women. Dashe et al found decreased rates of fetal anomaly 
detection in standard or targeted ultrasound with rising BMI. The detection of anomalous 
fetus was 66% with normal BMI and 49 for overweight women, 48% for class I obese, 
42% for class II obese and 25% for class III obese women. Hendler et al found increasing 
rates of suboptimal visualization with increasing BMI(51). The study concluded that the 
optimal gestational age for visualization is 18-20 weeks. Khouri et al found higher 
suboptimal visualization in obese women with cardiovascular system, facial soft tissue 
and abdominal wall. There was improvement in visualization with increasing gestational 
age (52).Similar findings were found in other studies also (53)(54). 
In third trimester the fetuses can be macrosomic even in the absence of diabetes. Thus 
estimation of fetal weight gives important information for prediction of birth injuries due 
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to macrosomia. Farell et al found that ultrasound is the most effective method for 
estimation of fetal weight in obese and in non-obese women (55). 72% of estimates were 
within 10% of estimates. Ryan et al did not find obesity to have significant impact on 
fetal weight estimation accuracy. 
These limitations in visualization can be reduced by applying knowledge of ultrasound 
physics. The lower frequency ultrasound probes like trans-abdominal probes can give 
deeper penetration at the expense of higher resolution but higher frequency probes like 
trans-vaginal probes achieve higher resolution but have lower penetration. The use of 
tissue harmonics index can also improve visualization quality. Clarity of the image can 
also be improved by increasing gain and increasing brightness of the image in the 
targeted area. Ultrasound frequency can also be adjusted to give better images. In truncal 
obesity the patient can be positioned to the side and the „umbilical window‟ used or 
elevate the pannus and scan below it to decrease distance of insonation. 
 
OBESITY AND LEPTIN 
Leptin is located on chromosome 7q32. BMI is highly associated with leptin 
concentrations.  Studies show that overeating  increases leptin concentration by 40% 
whereas starvation reduces the same by 60-70% in 48 hours(56)(57). 
Leptin concentration is more in women compared tomen and more in pregnant when 
compared to non-pregnant women(58).Ethnicity doesnot seem to cause change in leptin 
concentrations. The concentration seems similar in patients with T2DM with same 
weight, but existence of hyperglycemia causes increased leptin production(59)(60).There 
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are atleast five forms of leptin receptor, of which the short form is the widely distributed. 
It is present in most tissues and transports leptin to brain. The long form is located in 
places like hypothalamus and brain stem nuclei. Leptin is primarily produced by adipose 
tissues and placenta and is regulated by estradiol. In stomach it is released into the 
intestines from where it is absorbed. Large fat cells produce more leptin than the small 
ones and are highly related to the fat content of the body. During starvation Leptin m 
RNA and secretion by adipocytes decline, suggesting that leptin signals brain about the 
quantity of stored fat. This is mediated by insulin, glucocorticoids and TNF alpha.  In 
pregnancy and neonatal period placenta and breast milk serve as source of leptin. 
Leptin concentrations are higher in childhood and more in children gaining more weight. 
It is also higher in those having early onset of puberty(58).  There is diurnal variation of 
leptin with  20-40% higher concentration in the middle of night (61). The peak shifts in 
accordance to timing of meals. Plasma leptin is also related to blood pressures in 
normotensive and hypertensive individuals (62)(63). Congenital leptin deficiency 
produces massive obesity (64). Omega-3 supplementation can reduce leptin levels in non-
obese but not in obese individuals (65). Leptin administration produces menstruation in 
hypothalamic amenorrhoea by improving hypothalamic, thyroid and growth hormone 
axis. 
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MSH- melanocyte stimulating hormone, ART- agouti-related transcript, CRH- 
corticotropin releasing hormone, GHRH –growth hormone releasing hormone, GnRH- 
gonadotropin releasing hormone, SNS- sensory nervous system, PNS- parasympathetic 
nervous system. 
 
OBESITY, INFLAMMATION, INSULIN RESISTANCE: 
Adipocytes secrete the following: 
 
Obesity causes increased triglyceride storage which causes hypertrophy and hyperplasia 
of adipocytes.  This cellular dysfunction causes release of adipokines, free fatty acids and 
adipokines. Excessive circulating free fatty acids cause fat accumulation in skeletal 
muscle, liver, heart, and pancreatic β islet cells This fat accumulation causes increase in 
peripheral insulin resistance by reducing insulin mediated uptake of glucose. It causes 
systemic hyperinsulinemia and in the liver it causes acceleration of gluconeogenesis. 
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Obesity causes a state of chronic low grade inflammation which occurs in liver and 
adipose tissue is called meta inflammation due to its aberrant nature(66)(67).Various 
stress signals like FFA, pro inflammatory cytokines, reactive oxygen species causes 
activation of the JUN N –terminal kinase. Modulation of insulin signaling induces serine 
phosphorylation of insulin receptor IRS-1 leads to insulin resistance(68)(69). 
Studies have shown increased inflammatory response systemically and within adipose 
tissue and placental tissue in women with pre pregnancy obesity which probably plays a 
role in adverse pregnancy outcomes(70)(71). 
 
RELATIVE INSULIN 
DEFICIENCY 
DECREASED FUNCTION AND 
APOPTOSIS OF BETA CELLS 
- SYSTEMIC HYPERINSULINEMIA 
   - INCREASED GLUCONEOGENESIS 
INCREASED  
FFA 
REDUCED HEPATIC 
INSULIN EXTRACTION 
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OBESITY AND FAT LOCATION: 
Visceral adiposity is related to insulin resistance and thus to dyslipidemia, 
hyperinsulinemia, metabolic syndrome. The visceral fat is less sensitive to insulin and 
more catecholamine induced lipolysis sensitive. Due to portal venous system, its in direct 
contact with liver. This causes constant liver exposure to non-estrified fatty acids which 
causes alteration in liver metabolism and causes hepatic insulin resistance. The resistance 
to insulin is further increased by the inflammatory mediators. 
The subcutaneous fat is the primary fat storage depot and the storage in other areas is 
after saturation of primary depot.  The storing capacity is greater in women as compared 
to men. Same theory explains the reason why south Asians are at greater risk due to 
central obesity(72)(73). This also explains how weight loss restores metabolic and 
clinical benefits. 
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OBESITY, PREGNANCY AND ALTERED METABOLISM 
Maternal obesity alters the metabolic adjustments of pregnancy which in turn affect the 
placental, embryonal, fetal development and maternal physiological changes.Obese 
women have increased leptin and decreased adiponectin which causes increased insulin 
Subcutaneous fat  
Metabolically good 
Primary depot 
Visceral 
fat 
Ectopic fat 
Metabolic and vascular 
complications 
Ethnicity 
Genes programming 
sex 
5% weight loss  
~30% visceral fat loss 
Skeletal muscle, 
liver, heart 
35 
 
resistance. This in turn induces increased nutrient transfer across placenta. This in turn 
induces fetal hyperinsulinemia. 
Pregnancy is a state of accelerated starvation where glucose is reserved for the fetus and 
alternative energy source is utilized for maternal requirements. In early pregnancy there 
is hyperplasia of pancreatic β cells. There is an early insulin sensitivity followed by 
insulin resistance which begins in second trimester and peaks in the third trimester. This 
is due to placental diabatogenic hormones GH, CRH, h CS, progesterone. TNF and 
placental growth hormone is also contributory to this effect(74). 
Insulin levels are high in fasting state and in post prandial state. The fasting glucose 
levels are 10-20% lower because of increased storage of glycogen in tissues, increased 
peripheral utilization of glucose, decreased hepatic glucose production and increased 
glucose consumption by fetus.The increased lipolysis allows usage of free fatty acids, 
triglycerides and ketone bodies for energy. This preserves glucose and amino acids for 
the baby and minimizes protein catabolism. 
Change in lipid profile in pregnancy:       
 95th percentile of 2nd and 3rd trimester 
 Mg/dl Mmol/L Mg/dl Mmol/L 
Total triglyceride 254 mg/dl 2.87  415   
 
4.68 
Total cholesterol 319       8.24 380 9.83 
LDL cholesterol 217 5.61 251 6.48 
 5th percentile 
HDL cholesterol 42 1.09 40 1.04 
(75)(76)(77) 
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This increase in triglycerides seems to be due to enhanced hepatic lipase activity causing 
enhanced hepatic triglyceride synthesis and reduced lipoprotein lipase activity. 
Apolipoprotrins A-I, A-II and B rise with advancing gestation and HDL – cholesterol 
levels initially rises then falls through advancing gestation (75). These adaptations are for 
meeting fetal requirements. Elevated LDL cholesterol levels also helps in placental 
steroidogenesis. Thus fat accumulation occurs in 2
nd
 trimester and consumption of stored 
fat occurs in the 3
rd
 trimester. 
 
OBESITY AND METABOLIC SYNDROME: 
The combination of obesity with dyslipidemia and hypertension is called metabolic 
syndrome or syndrome X. The various defining criterion are tabulated in table-1 
Insulin resistance and hyperinsulinemia form the common pathway for hypertension and 
diabetes and metabolic syndrome in pregnancy. Metabolic syndrome as discussed is 
associated with endothelial dysfunction, oxidative stress and decreased inflammatory 
response. 
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(78)(79) 
• STORAGE IN ADIPOSE TISSUEEARLY 
PREGNANCY
• LIPOLYSIS 
• HYPERLIPIDEMIA
LATE PREGNANCY
PERIPHERAL INSULIN 
RESISTANCE 
INCREASED TRIGLYCERIDES 
AND LIPOPROTEINS 
POSTPRANDIAL INCREASED INSULIN 
ANTILIPOLYTIC ACTION 
SUPRESSION OF FFA FROM ADIPOSE 
TISSUE PREGNANCY 
INCREASE IN INSULIN RESISTANCE 
DECREASE ABILITY OF INSULIN TO SUPRESS FFA LEVELS 
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Increased weight gain leads to insulin resistance which leads to secondary 
hyperinsulinemia. This leads to extracellular volume expansion due to sodium retention 
by the kidneys due to the sympathetic activity  due to insulin(80). These are the factors 
leading to the constellation of metabolic syndrome. 
 
OBESITY AND GDM: 
The changes in glucose and fat metabolism and insulin resistance have been discussed. 
With advancing pregnancy insulin mediated glucose uptake worsens by 40-60% and 
insulin secretion increases several fold to maintain euglycemic state.  In obesity there is 
marked increase in peripheral and hepatic insulin resistance.  Thus overweight, obese 
women are 2 and 4 times more likely and the severely obese are nine times more at risk 
for developing GDM as compared to the leaner counterparts(81)(82)(83)(84).The insulin 
resistance is brought upon by increased maternal adiposity and antidiabatogenic placental 
hormones. The women with obesity existing pre-conceptionally are at higher risk for 
insulin resistance. This explains why leaner women have lesser risk. The Asians due to 
greater visceral obesity are more susceptible to ill effects of obesity thus the cut off points 
are different as mentioned before.As compared to European women Indian women have 
11 fold increase in prevalence of GDM(85). 
Later in pregnancy there is increased adipose tissue lipolysis which leads to 
hyperlipidemia, increased triglycerides, increased cholesterol and increased circulating 
lipoproteins. In the fasting state there is a decrease in insulin levels which leads to 
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increased lipolysis which in turn causes increased levels of free fatty acids (accelerated 
starvation of pregnancy). In the 3
rd
 trimester of pregnancy there is increase in 
triacylglycerol and decrease in HDL concentrations(86)(87)(88).  There is also decrease 
in LDL and VLDL due to insulin resistance and effect of increased amount of estrogen 
on catabolism of LDL cholesterol. A positive co relation has been found between 
increased levels of maternal serum triglycerides and birth weight andfat mass of the baby 
in women with gestational diabetes. This is the mechanism adding to macrosomia. Since 
obesity is a state of hyperinsulinemia, hyperlipidemia, chronic inflammation, the 
overweight and the obese women have increased risks of adverse pregnancy outcomes 
even with good glycemic control(89). The changes in leptin and adiponectin and changes 
in sugar control are as discussed above.  The women with gestational diabetes are at risk 
of developing T2DM later in life and obesity is a major risk factor (90).  Some of the 
adverse outcomes in GDMthat further worsen obesity are macrosomia and caesarean rate 
which is more in those with poorer glycemic control (91)(92). GDM, overt diabetes and 
mild gestational hyperglycemia were all found to have oxidative DNA damage. Diabetic 
women had more oxidative stress but in mild gestational hyperglycemia obesity and 
insulin resistance seems to be the cause. Type of DNA base affected depended on 
glycemic control(93). 
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OBESITY AND HYPERTENSVE DISORDERS: 
Classification: 
 HYPERTENSIVE DISORDERS IN PREGNANCY 
1. Pre-ecclampsia/ecclampsia( BP elevation at gestation > 20 weeks with proteinuria or 
any of the severe features of preeclampsia 
2. Chronic HTN (any of the cause that predates pregnancy) 
3. Chronic HTN with superimposed preeclampsia 
4. Gestational HTN (elevation of BP at gestation > 20 weeks in the absence of 
proteinuria or any of the features of preeclampsia 
HTN = hypertension 
One among known risk factors for hypertensive disorders in pregnancy is obesity. 
Studies have shown higher pre pregnancy BMI, excessive weight gain in pregnancy as 
risk factors for GHTN(94)(95)(96). The relative risk is 1.7 and 5.2 for 5-10 kg weight  
gain and ≥ 25 kg weight gain respectively(97). Kazemian et al showed that women in 
highest quartile of mid arm circumference were at 3 fold risk of gestational hypertension 
as compared to those in the lowest quartile. So compared to women with normal BMI, 
the obese and the morbidly obese had higher 1
st
 trimester systolic BP readings and similar 
trend continued in second and third trimester. The risk of pre ecclampsia was higher in 
obese women(95). The risk of pre ecclampsia doubles every 5-7 kg/m2  rise in pre 
pregnancy BMI(96). This relationship persisted even after excluding people with chronic 
hypertension, multiple pregnancy and diabetes mellitus.  Any maternal or fetal factor 
enhancing the endothelial dysfunction predisposes to pre ecclampsia. Thus obesity, 
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diabetes are associated with increased risk(98). Plasma nitric oxide levels are elevated in 
obese mothers but reduced in GHTN.Prothrombin and fibrinogen levels are elevated in 
obese and hypertensive mothers. APTT, protein C, protein S, antithrombin levels are 
higher in gestational hypertensive women. Thus obese hypertensive mothers are in a pro 
thrombotic state(99). 
Pre pregnancy or adult weight gain is proven to be predisposing to pre ecclampsia and 
GDM(100). The hormonal and biochemical changes exist before pregnancy, early in 
pregnancy, before onset of pre ecclampsia and months after delivery. Hence optimizing 
pre pregnancy BMI and limiting gestational weight gain would limit metabolic 
abnormalities of dyslipidemia, hypertension, IR, increased coagulopathy, inflammatory 
mediators, apokine profiles and improve pregnancy outcomes.  These obese women are at 
risk of cardiovascular diseases later in life due to common risk factors(101) but there is 
no association between pre ecclampsia and future  malignancy(102). 
 
OBESITY AND BP MEASUREMENT 
American Heart Association 2005 has given BP cuff measurements according to mid arm 
circumference which is given in the following table: 
MID ARM CIRCUMFERENCE 
In cms 
BP CUFF SIZE in cms 
22-26 12 x 22  small adult 
27-34 16 x 30 adult 
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35-44 16 x 36  large adult 
45-52 16 x 42  adult thigh 
 
Society of obstetric medicine of Australia and New Zealand suggests that the cuff bladder 
covering 80% of arm circumference should be used. For arm circumference >33 cms and 
<44 cms and a thigh cuff should be used if arm circumference is > 44 cms. 
New York state department of health states that the cuff should encircle 75-100% of the 
upper arm and the cuff mid-point and the arm should be at the level of the heart (103). 
 
OBESITY AND INDUCTION OF LABOR: 
Scotland et al showed a progressive relationship between increasing BMI and prolonged 
gestation. 28.5% of obese women reached beyond 41 weeks compared to 21.9% of 
women with normal BMI. Obese women had 69% higher odds of crossing 42 weeks as 
compared to women with normal BMI with OR of 1.69 (95% CI,1.23-2.31)(104)(105).  
Arrowsmith et al showed that more than 60% of obese primiparas and 90% of 
multigravidas who were induced for prolonged pregnancies had vaginal deliveries and 
the labor complications between obese and those with normal BMI were 
comparable(106). The results are significant considering the vast number of women 
delivered by elective induction of labor or elective 
caesarean(91)(105)(107)(108)(109)(110). The exact mechanism behind prolongation of 
gestation in obesity is not clear. The postulated theory is that endocrine factors necessary 
for initiation of labor are altered by the hormonally active adipose tissue. IOL is also 
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required more due to associated co morbidities of GDM, hypertension, pre ecclampsia. 
After adjusting for presence of pre ecclampsia also morbidly obese women are more 
likely to be induced when compared to normal BMI women(111).  In the study by 
Arrowsmith et al, the number of women requiring induction of labor also increased-
26.2% of normal BMI women, 30.5% of overweight women and 34.4% of obese women. 
Induction of labor should be done for obstetric and medical indications and not for 
obesity alone (107)(112). 
 
OBESITY AND LABOR DYSTOCIAS 
Evidence shows decreased uterine contractility in the obese(113)(114) and of prolonged 
duration of labor (115)(116)(117).It is hypothesized that there is altered cholesterol levels 
which decreases the myometrial contractility (113).  Some inhibitory action of the 
increased levels of  leptin has also been hypothesized (114).  The duration of labor was 
prolonged even after adjusting for maternal height, labor induction, PROM, oxytocin 
augmentation, fetal size and epidural analgesia. This prolonged labour puts them at 
higher risk of chorioamnionitis which further results in slowing of labor progress. 
 
OBESITY AND INCREASED CAESAREAN RATE: 
The risk of caesarean section is more than double in women with obesity as compared to 
women with normal BMI (91).Obesity has been associated with delay in progress of 
labor, malpresentation and macrosomia. Thus there is increased cesarean rate with 
increase in BMI, 27.8% in obese and 10.8% in non-obese. Obesity has also been found to 
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be an independent  risk factor for increased cesarean 
rate(81)(118)(119)(120)(121)(122)(123).CMACE report shows that the rate of caesarean 
was 37% in BMI > 35 kg/m2 and 46% when BMI was > 50kg/m2. 
 
OBESITY AND CONSIDERATIONS DURING CAESAREAN SECTION: 
Antibiotic prophylaxis: 
From the data on non-pregnant obese people it is evident that the tissue penetration of 
drugs is impaired in obese people(124). The antibiotic dosage according to ASHP 
guidelines is 2g of Cefazolin for weight > 80 kgs and 3g for weight > 120kgs(125)(126). 
Studies show that more than standard dosage is required for reaching minimum inhibitory 
concentration in obese people(127).The concentration of antibiotic in adipose tissue were 
inversely proportional to maternal BMI and considerable percentage of women did not 
achieve minimal inhibitory levels for gram negative bacilli at skin incision but there was 
no significant difference at skin closure(128). The antibiotic given pre operatively 
significantly reduces the risk of postpartum endometritis(129)(130). 
 
Obesity and skin incision: 
The preferable type of skin incision is controversial. Studies show variable results. 
Cohort studies done in women with BMI > 35kg/m2 show higher risk of wound 
infections and wound related complications with vertical incision(131)(132)(133). 
Retrospective cohort studies have also shown no difference between pfannensteil and 
vertical incision(134)(135). A large retrospective cohort study showed significant lower 
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rate of wound complications with vertical skin incisions(136). Thus the results are very 
conflicting. 
 
Obesity and subcutaneous tissue closure: 
Evidence shows that closure of subcutaneous layer when the thickness is > 2 cms is 
associated with decrease in postoperative wound complications, especially seroma 
formation(137)(138). The cochrane database shows low quality evidence for supporting 
or refuting(139). 
 
Obesity and subcutaneous drain placement during caesarean: 
Studies showed no difference in the wound complication rates in obese women with 
routine drain placement(140). A retrospective study of women with BMI>50 kg/m2 
showed an increase in the wound complications with use of subcutaneous drains(133). 
Obesity and anesthetic challenges for caesarean: 
Regional anesthesia is preferred method of analgesia in obese and non-obese patients  
due to lesser rate of complications(141). In obese patients regional anesthesia is difficult 
as bony landmarks are obscured by the adipose tissue. Thus they are more likely to get 
multiple punctures for epidural anesthesia or subarachnoid blockade(142). The intubation 
also is difficult in obese patient and can cause major problems in emergency 
situation(143). Thus adequate preparations should be kept ready and the anesthetist 
informed beforehand(144)(145). The incidence of multiple dural puncture and post dural 
puncture headache is higher in obese women(146). The rates of failed regional anesthesia 
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is also higher in obese and morbidly obese women(142). The soft tissue changes in 
pregnancy is further complicated by obesity because of short neck, increased soft tissue 
and decreased mobility. The heavier breast tissue mass decreases the ventilation due to 
decrease in lung capacity. This leads to need of fiber optic technique and use of laryngeal 
mask airways. In dire emergency situations cricothyrotomy may be required(147). 
 
OBESITY AND PRETERM BIRTH: 
Obesity increases the risk of pre ecclampsia and GDM hence increasing the rate of 
preterm delivery for iatrogenic  reasons(148)(149). The risk of spontaneous pre term birth 
among obese is not well known. Spontaneous labor is however associated with PPROM 
(111). This is because of state of chronic inflammation and active inflammatory 
cytokines. The rate of labor inductions for PROM, PPROM is higher in the obese 
women. The preterm births are thus medically induced (150). Thus they are at higher risk  
of obstetrical interventions(151)(152). There is higher risk of UTI and genital infections 
increasing the risk of chorioamnionitis(91). 
A population based study showed that in healthy term singleton pregnancies obesity 
doesnot increase the risk of neonatal admission to ICU or duration of hospital 
stay(153).Considering the raise in labor inductions, the rise in caesarean rate and pre term 
births decreasing maternal obesity can decrease the burden of preterm birth. 
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OBESITY AND INSTRUMENTAL DELIVERY 
Instrumental deliveries are challenging in obese women due to associated macrosomia 
and shoulder dystocia. Various studies have shown conflicting results. In morbidly obese 
some studies show higher instrumentation rates (109) whereas the others show lower 
rates (154) probably as a reflection of higher caesarean rates. 
 
OBESITY AND MACROSOMIA 
Pre pregnancy BMI is an important influencing factor for birth weight(155)(156). Obese 
women are at risk of fetal macrosomia which may be reflection of medical complications 
(155) Obese women are 2 to 3 times more likely to have LGA babies even after 
adjustment for diabetes(119)(157)(158)(159)(160). The insulin resistance and 
hyperglycemia seem to play a major role. Fetal macrosomia is related to not only the 
absolute size of the fetus but also to the change in body composition and increase in fat 
percentage in the obese and the overweight(161)(162).Macrosomia rate of >10% was 
associated with ≥ 15 kg weight gain in women of BMI 25-29 kg/m2 and with a weight 
gain of ≥ 10 kg in women of BMI more than 30 kg/m2. In women with BMI ≤ 25 kg/m2 
the macrosomia rate was < 10% irrespective of the weight gain during pregnancy(163). 
The complications associated with macrosomia are increased risk of operative vaginal 
delivery, malpresentation, caesarean section, PPH, low APGAR scores, admission to 
NICU(155). 
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OBESITY AND SHOULDER DYSTOCIA: 
Data on shoulder dystocia are conflicting. Somestudies show that shoulder dystocia was 
significantly higher in women with obesity (111) and that obesity was an independent 
risk factor(160). But study of pregnant women with BMI >50kg/m2 showed no increased 
risk. This may be because of the high cesarean rate (164).A population based study by 
Sheiner et al didnot show obesity as an independent risk factor for shoulder dystocia 
(157). Robinson et al also concluded similar results and found fetal macrosomia as 
strongest predictor (165).For obese non diabetic women with normal fetal weights, the 
risk of shoulder dystocia is not increased(157). 
 
OBESITY AND APGAR SCORES 
The adjusted odds ratio of APGAR <7 was 31% for obese compared to 26% for non-
obese. The NICU admission rates were also higher  even after adjusting for labor 
inductions and caesarean delivery(166). Neonatal metabolic abnormality rate was also 
higher in obese women with extreme obesity(167).Some studies show obesity alone after 
excluding the risk factors due to GHTN and GDM did not pose as a risk factor for lower 
APGAR scores(157). In the massively obese women the complications seem to be due to 
medical complications of obesity(155). 
 
OBESITY AND RISK OF STILL BIRTH 
Obesity is a modifiable risk factor regarding still birth. A systematic review showed that 
overweight and obese pregnant women were at higher risk of still birth thanwomen with 
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normal BMI(168)(109)(169)(132). The explanation for the association is not well 
explained but seems to be due to complications like GDM and pre ecclampsia and the 
technical difficulties with cardiotocography and ultrasound scans due to 
obesity.Asystematic review done in 2014 showed that women with BMI 40 kg/m2 had 
twice the risk of still birth compared to the women with BMI of 20 kg/m2(170). Extreme 
obesity is a significant risk factor for stillbirth(169).Super obese women were at 5.7 times 
more risk of still birth at 39 week compared to women with normal weight at 41 
weeks(171). Some studies show a higher risk of still birth in obese but no difference in 
the overweight category(172). There is no association between maternal weight gain in 
pregnancy and still birth(173)(174)(175)(176). Interpregnancy weight gain of > 3 kg/m2 
has been found to increase risk of still birth independently(177). Obstructive sleep apnea 
in obese women and oxygen desaturation also puts these women at risk for still 
birth(178). Whether the age and risk factors other than those as a consequence of obesity 
are different in different time points has not been studied. The limitation with 
observational studies is unmeasured multiple confounding factors. However all the above 
quoted studies show a dose dependent relationship between BMI and still birth even 
when adjusted for relevant risk factors of gestational diabetes, GHTN, race, parity, 
smoking etc. Most of the still births in obese women are either unexplained or due to 
placental insufficiency. The exact mechanism is not known but the proposed theories 
include placental dysfunction, placental insufficiency, insulin resistance, hyperlipidemia 
etc (179)(73)(180). 
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Other risk factors 
Chronic HTN 
Diabetes 
OSA 
Advanced maternal age 
African American race 
Interpregnacy weight gain 
GA 
 
 
 
 
 
 
Risk of still birth and GA (171) 
There is a brisk increase in still birth in obese women near 37 weeks(171)(175)(174). The 
reason for the same is uncertain. However inducing all the obese women for this less 
common outcome is not reasonable. 
 
OBESITY AND STILL 
BIRTH 
Placental dysfunction 
Placental inflammation 
Insulin resistance 
Hyperlipidemia 
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OBESITY AND PERINEAL LACERATIONS 
A higher risk of second degree but not 3
rd
 or 4
th
 degree has been found in obese 
primiparous women(119). The rates of third degree and shoulder dystocia were not found 
to be significantly different(154).  Blomberg et al showed that the rates of 3
rd
 and 4
th
 
degree perineal tears and risk of serious anal sphincter injuries decreased with increasing 
BMI(181)(182). Gallagher et al also found that higher BMI or excessive weight gain in 
pregnancy was not associated with higher rates of perineal injuries(183). This may be due 
to higher cesarean rates among the obese which might otherwise have ended in 
challenging instrumentations or shoulder dystocias and perineal injuries. 
 
OBESITY AND PPH 
As discussed above prolonged labor, augmentation of labor, chorioamnioitis is associated  
with increased risk of postpartum hemorrhage(91)(121).In women with BMI > 30 kg/m2 
active management of third stage of labor has been recommended. It reduces PPH, 
duration of third stage of labor, the requirement of  oxytocics and blood transfusion and 
hence the risk of postpartum anemia also(184)(185)(105)(186).  Sebire et al found that 
the risk of PPH existed even after removal of confounders like the mode of delivery.  
Fyfe et al found that the risk of PPH of >1L  in obese women was 2 fold more. Compared 
to women of normal BMI, Vinayagam et al found that women with BMI > 40 kg/m2 
were three times more at risk of PPH(187). Thus active management of third stage of 
labor should be undertaken to minimize the blood loss(186). 
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OBESITY AND SEPSIS 
Obesity is an independent risk factor for infections and sepsis including all from surgical 
site infections, chorioamnionitis, endometritis, urinary tract infections, skin and soft 
tissue infections, hospital acquired infections(91)(188)(189). Magann et al showed that 
BMI > 32.5 and weight gain more than 28 lb by 28 weeks were at increased risk of 
wound infection and endometritis(188).  
The definitions of sepsis are tabulated in Table 9.  Animal and epidemiological studies 
have proven increased susceptibility of viral and bacterial infections with 
obesiy(190)(191)(192).  
 Operating obese patients takes more time due to technical difficulties.  CMACE/ RCOG 
joint guidelines 2010 suggest that specialty trainee of level year 6 or above be present for 
operating on morbidly obese patient. The rate of cesarean section is more with increasing 
class of obesity. Though there is more risk of chorioamnoinitis and endometritis and 
wound infections in obese women, there is no evidence to suggest that the morbidity is 
less with elective cesarean section.  Wound infection rates are double and go on doubling 
for increment of 5 units of BMI(133).  Alanis MS et al showed that with BMI > 50 kg/m2 
30% developed wound complications, 90% developed wound disruptions, 24% needed 
readmissions, 14% needed repeat surgeries in theatre and nearly 1%  had evisceration. 
The use of subcutaneous drains was found to increase the risk of infections. In obese 
women aorto caval compression is more profound and hence a lateral tilt of >15 degrees 
is recommended. Hypothermia and hyperglycemia increases the chance of postoperative 
wound infections(193)(194). Thus optimum temperature control during the operating 
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procedure is important. Subcutaneous wound irrigation has not been found to decrease 
the infection rates. 
Skin incision should be lower transverse which gives adequate exposure. The symphysis 
pubis is difficult to palpate and hence precautions should be taken to avoid bladder 
injury.  Appropriate use of assistants and surgical mops should be done to avoid visceral 
injury.  Alexis O cesarean section retractor- is a relatively new device for maximizing 
exposure. It may seem logical to think that vertical skin incision gives better exposure. 
But vertical incisions were associated with more postoperative pain, wound infection, 
atelectasis apart from making access to lower segment difficult(195)(133). 
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OBESITY AND VTE 
Pregnancy is a prothrombotic state and there is upregulation of coagulation factors. With 
obesity there is also change in inflammatory pathway which further augments this. The 
risk factors that heighten the existing risk of VTE for obese women is operative delivery, 
pre ecclampsia and assisted reproduction(197)(198)(161).  Between 1991 and 2005 
thromboembolism is the leading cause of maternal mortality in UK, half of them being 
pulmonary embolism in overweight and obese women. The risk of VTE with obesity was 
FACTORS INCREASING RISK OF 
INFECTION 
-Young age 
-Multiparity 
-Labor induction 
-Ruptured membranes 
-Pretermbirth 
-Operative deliveries 
-Manual removal of placenta 
-Anemia 
-Diabetes Mellitus 
-Cervical cerclage 
-GBS carriers 
-Immunosuppresion. 
 
FACTORS DECREASING 
IMMUNITY 
*Supression of functionality of both  
CD4 T cells and CD8 T ells 
*T cell proliferation and suppression 
*Impaired NK cells 
*Decreased cytokine production 
PACENTAL IMMUNOSUPRESSION 
*Lack of majority of class 1a MHC antigens by fetal  
  trophoblasts to aoid maternal rejection 
*MHC1b antigens inhibit migration of NK cells   
  through placenta to protect fetal trophoblasts 
*Apoptosis in placenta destroys activated maternal  
  immune cells 
*Specialised uterine NK cells that ignore semi   
  allogenic fetal cells 
*Selective transfer of only beneficial maternal IgG  
  antibodies 
*NK cells, T cells, dendritic cells and macrophages  
  migrate to placenta causing their peripheral  
  inavailability 
OBESITY AND RISK OF 
SEPSIS 
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increasingly clear and thus in 2004 RCOG brought out guidelines for 
thromboprophylaxis for women at risk.  After establishment of guidelines by RCOG on 
thromboprophylaxis, there was a dramatic decrease in maternal deaths from VTE by 
2008 in UK, but preventable deaths still continue(199)(200). US nationwide inpatient 
sample study showed that 50% of VTE happened in pregnancy and 50% happened in the 
postpartum period. The risk of VTE is increased 4 fold in pregnancy and increased 20 
fold to 99/10,000 woman years in postpartum period (201)(202). The period of highest 
risk is around delivery from 2 day before to 1 day after delivery (203). A National 
Inpatient Sample study over 1994-2009 estimated a 14% increase in the rate of overall 
pregnancy associated hospitalizations for VTE. The rate of delivery hospitalizations was 
constant but there was 17% increase in antepartum and 47% increase in postpartum 
hospitalizations. The prevalence of hypertension and obesity was increased 2 fold among 
VTE associated admissions. The increased  risk of VTE continues  for 6 weeks after 
delivery but the return time of risk to baseline is not very clear from a 2011 systematic 
review(201). Recent study shows persistence of risk upto 12 weeks though the absolute 
risk is low after 6 weeks postpartum(204). 
Obesity is one of the risk factors for VTE, most striking risk factors for VTE were(204) : 
-Thrombophilia (OR 51.8) 
-History of previous thrombosis (OR 24.8) 
-APLA syndrome (OR15.8) 
- Lupus(OR8.7) 
- Heart disease (OR 7.1) 
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- Sickle cell disease (OR 6.7) 
- Obesity (OR 4.4) 
- Smoking (OR 1.7) 
- Age more than 35 years (OR 1.4) 
Of these thrombophilia and past history of VTE are the most important. When history of 
previous VTE was excluded hyperemesis, multiple pregnancy, infection increased the 
risk of VTE in pregnancy and in puerperal period was increased by obesity, PPH, 
caesarean section and infection (205)(206). Hospitalization was the most important factor 
during pregnancy and puerperium. 
Venous blood flow is decreased by 50% in the third trimester of pregnancy. In obesity 
decreased mobility and increased venous stasis are additive factors. VTE is more 
common in left leg than right which is probably due to compression of left iliac vein by 
the overlying right iliac artery. In pregnancy this effect is increased and 85% of DVT 
effects left lower limb(207). The adipokines in obese women is prothrombotic and 
proinflammatory. There is also elevated level of fibrinogen and factor VII, a state of 
chronic inflammation and impaired fibrinolysis. Leptin causes increased fibrinogen and 
platelet adhesion and may also generate active tissue factor thromboplastin which causes 
initiation of extrinsic coagulation cascade(208)(209). In metabolic syndrome there is 
enhanced platelet hyperactivity, hypercoaguability, hypofibrinilysis and endothelial 
dysfunction which increases the risk of thrombosis.  The chronic inflammation also 
reflected in high CRP, generation of pro-coagulant factors in vascular wall. In obesity 
there is also up-regulation of plasminogen activator inhibitor PAI-1, overexpression of 
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which has been linked in animal studies and has been found to be high in humans 
also(209). 
The circulating levels of adipokine leptin are increased in obesity. The leptin receptors 
existing on vascular cell types exert direct thrombogenic effects (209). Another adipokine 
adiponectin has anti -inflammatory and antithrombotic properties. Reduced levels of 
adiponectin is observed in obese individuals (210). 
Adipose tissue present intra abdominally is very active. In central obesity the 
subcutaneous tissue is decreased and there is increase in intra-abdominal and visceral fat. 
This is the key reason of metabolic syndrome. Non-obese individuals can also develop 
metabolic syndrome but the incidence is higher in the obese population (211). 
RCOG greentop guidelines no. 37a recommends that two risk assessments one at booking 
and one at delivery be made. If BMI > 30 kg/m2 then two more risk factors must be 
present for thromboprophylaxis. If there is hospitalization only one more risk factor is 
required to consider thromboprophylaxis.   The second risk factor assessment is at 
delivery. If BMI >40 kg/m2 it in itself an indication for thromboprophylaxis for 7 days 
postpartum. If BMI >30 kg/m2 then one more risk factor is needed for 
thromboprophylaxis for one week postpartum. 
Risk assessment profile for thromboembolism in caesarean section 
LOW RISK →Early mobilization and hydration. 
 
→Elective caesarean section ,uncomplicated pregnancy and no 
other risk factors 
 
MODERATE RISK →Consider one of a variety of prophylactic measures 
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→Age>35 years 
 
→Obesity(>80 kg) 
 
→Para 4 or more 
 
→Gross varicose veins 
 
→Current infection 
 
→Pre-eclampsia 
 
→Immobility prior to surgery(>4 days) 
 
→Major current illness, for example, heart or lung disease, 
cancer,inflammatory bowel disease, nephrotic syndrome 
 
→Emergency caesarean section in labor. 
 
 
 
HIGH RISK 
 
 
→Heparin prophylaxis ± leg stockings 
 
→A patient with three or more moderate risk factors from  
above 
 
→Extended major pelvic or abdominal surgery. Eg: Caesarean  
hysterectomy 
 
→Patients with a personal or family history of deep vein  
thrombosis, pulmonary embolism or thrombophilia, paralysis  
of the lower limbs 
 
→ Patients with antiphospholipid antibody (ACA or LA) 
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Risk of VTE: 
Antepartum Postpartum 
→Multiple births 
 
→Varicose veins 
 
→ Inflammatory bowel disease  
 
→Urinary track infection 
 
→Diabetes 
 
→Hospitalization for non-
delivery(Particularly   
    those> 3 days) 
 
→ Body mass index(BMI)≥30Kg/m2 
 
→ Increased maternal age ≥35 years 
 
→Cesarean Delivery 
 
→Medical comorbidities(eg: varicose  
veins ,cardiac disease, inflammatory 
bowel disease) 
 
→Body mass index(BMI)≥25Kg/m2 
 
→Young  gestational age(preterm 
delivery<36 weeks) 
 
→Obstetric  hemorrhage 
 
→Still birth 
 
→Increased maternal age ≥35 years 
 
→Hypertension 
 
→Smoking 
 
→Eclampsia or preeclampsia 
 
→Postpartum infection 
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Transient factors Percentage 
More than 48 hours of immobility in the preceding month 45% 
Hospital admission in the past three months 39% 
Surgery in the past three months 34% 
Malignancy in the past three months 34% 
Infection in the past three months 34% 
Current hospitalization 26% 
 
The risk factors are mentioned above and table-2 list the various risk factors in pregnancy 
and peurperium and in the post cesarean period. The table below gives the weight 
adjusted dosage of LMWH.Graduated compression stockings are widely recommended 
for women at risk but the evidence is gathered from non-pregnant population. 
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Algorithm for DVT diagnosis: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CUS : compression ultrasound. 
 
 
 
 
 
 
Suspected DVT in pregnancy 
Proximal vein CUS 
Positive 
Negative  
Negative 
Negative Positive 
Clinicalfollow up Treat Treat 
Clinical 
SuspicionHigh 
Clinical 
Suspicion 
Low/Moderate 
Alternative 
imaging 
Positive 
Serial CUS 
(DAY 3 AND 7) 
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Antenatal and postnatal thromboprophylaxis  
Weight(Kg) Enoxaparin 
daily dosage 
Dalteparin 
daily dosage 
Tinzaparin(75µg/kg/day) 
daily dosage 
<50 20 mg  2500 units  3500 units  
50-90 40 mg 5000 units  4500 units  
91-130 60 mg * 7500 units  7000 units  
131-170 80 mg * 10000 units  9000 units  
>170 0.6 mg/kg/day* 75 units/kg/day 75 units/kg/day 
High prophylactic dosage 
for 50-90 kg 
40 mg 12 
hourly 
5000 units 12 
hourly 
4500 units 12 hourly 
Therapeutic/Treatment 
dose 
Antenatal:1 
mg/kg/12 
hourly 
100 units/kg/12 
hourly or 200 
units/kg/daily 
postnatal 
175 
units/kg/daily(antenatal 
and postnatal) 
*May be given in divided doses 
 
 
OBESITY AND SLEEP APNEA IN PREGNANCY 
The prevalence of obstructive sleep apnea in pregnancy is not well established. A cohort 
study by polysomnography of 105 pregnant women showed that apnea hypopnea index ≥ 
5 events /hour was 10.5 in first trimester and 26.7 in third trimester (212). 
The physiological changes that predispose to sleep apnea in pregnant women are: 
-Narrowing of oropharyngeal diameter 
-Reduced nasal patency secondary to hyperemia and edema of nasal mucosa. 
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-Blood volume increase in pregnancy and fluid shift to neck in recumbent position 
possibly increases sleep disordered breathing 
-Increased sensitivity of respiratory center  of brain to CO2, increased ventilator 
drive, increased minute ventilation and tidal volume predisposes to OSA. 
 
Obese women are more at risk for sleep related disordered breathing than women of 
normal weight (178). The described associations are with pre ecclampsia, intra uterine 
growth restriction, still birth. Further studies are required to establish the adverse 
outcome (213). 
 
OBESITY AND POSTPARTUM DEPRESSION 
DY La Coursiere et al showed that postpartum depression was 14.4% in normal weight, 
18.5% in pre obese, 18.8% in class I obese, 34.2% in class II, 40% in class III 
obesity(214).  Thus obesity is strongly associated with postpartum depression. New onset 
postpartum depression was associated with weight retention in first  postpartum 
year(215). 
 
OBESITY AND BREAST FEEDING 
Studies have shown that obese women are less likely to initiate, intend and continue to 
breast feed. They are also found to breast feed for shorter duration than normal weight 
women (216). These factors remain even when accounting for parity, educational status 
and age. Thus these women need extra postpartum care and support. 
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FETAL AND NEONATAL COMPLICATIONS  
The short term complications  were low APGAR scores, MSAF, shoulder 
dystocia,preterm and need for NICU care (217). There is observational evidence for in 
utero programming in offspring of obese women. And they are more likely to be obese in 
childhood and adult life (218)(219). These children are more at risk for cardiovascular 
diseases in adult life (220) The underlying mechanisms are under study (221). 
 
WEIGHT GAIN IN PREGNANCY 
Nutritional status in pregnancy committee and lactation of institute of medicine–IOM 
2009 gives guidelines for weight gain according to BMI categories. Tables below 
tabulate the same. 
 
 Total Weight gain 2nd and 3rd Trimester weight 
gain rates 
(Calculations assume a 0.5 -2 
kg(1.1-4.4lbs) weight gain in the 
first trimester) 
Pre pregnancy BMI Range in 
Kilograms 
Range in 
Pounds 
Mean(range) in 
Kilograms/week 
Mean(range) in 
Pounds/week 
Under weight(<18.5 
kg/m2) 
12.5-18.0 28.0-40.0 0.51(0.44-0.58) 1.0(1.0-1.3) 
Normal weight(18.50-
24.99 kg/m2) 
11.5-
16.50 
25.0-35.0 0.42(0.35-0.50) 1.0(0.8-1.0) 
Over Weight(25.00-
29.99 kg/m2) 
7.0-11.5 15.0-25.0 0.28(0.23-0.33) 0.6(0.5-.07) 
Obese(≥30.00kg/m2) 5.0-9.0 11.0-20.0 0.22(0.17-0.27) 0.5(0.4-0.6) 
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2009 IOM weight gain recommendations- Twin pregnancy 
Weight category BMI weight gain in 
pounds 
Weight gain in kg‟s 
Under weight <18.5 kg/m2 No recommendations due to insufficient 
data 
Normal weight 18.5 to 24.9 kg/m2 37 to 54 lbs. 16.8 to 24.5 kg 
Over weight 25 to 29.9kg/m2 31 to 50 lbs. 14.1 to 22.7 kg 
Obese ≥ 30 kg/m2 25 to 42 lbs. 11.4 to 19.1 kg 
 
 
OBESITY AND WEIGHT LOSS IN PREGNANCY 
There have been no randomized control trials on the same aspect. The safety and 
effectiveness is not established (222). There is reduction in birth weight. It may increase 
the preterm birth in class I obesity but weight loss of 5 kgs in class II, III obesity  has not 
shown to have SGA infants but also reduces the risks. It also reduced the risk of LGA 
babies, cesarean deliveries and pre eclampsia(223)(224)(225). 
2009 IOM weight gain recommendations- singleton pregnancy 
Weight category BMI weight gain in 
pounds 
Weight gain in kg‟s 
Under weight <18.5 kg/m2 28 to 40 lbs. 12,5 to 18 kg 
Normal weight 18.5 to 24.9 kg/m2 25 to 35 lbs. 11.5 to 16 kg 
Over weight 25 to 29.9kg/m2 15 to 25 lbs. 7 to 11.5 kg 
Obese ≥ 30 kg/m2 11 to 20 lbs. 5 to 9 kg 
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Weight loss and fasting is associated with ketonuria. The effect of ketonuria on 
pregnancy is not established in this scenario. 
 
 
OBESITY AND BARIATRIC SURGERIES 
80% of bariatric procedures are performed in women. 50% of these are in the 
reproductive age group(226). The procedure can be restrictive or malabsorptive. There 
are changes in physiology and anatomy which can affect absorptions of vitamins, 
minerals and medications. In laparoscopic gastric banding, the fluid volume in pregnancy 
can be adjusted to adjust for pregnancy related nausea and vomiting and prevent 
excessive weight gain (227). In obese women surgical and non-surgical weight loss helps 
in return of fertility. The return to fertility can be as soon as 2.1 to 3.4 months 
postoperatively. In a series 15 of 32 women who were unsuccessful to conceive, 
succeeded after bariatric surgery (228). Surgical weight loss leads to hormonal changes 
which cause decrease in androgens and insulin resistance which leads to return of 
ovulation(229). Women are advised to conceive 12-18 months after the surgery to avoid 
the adverse effects of nutritional deficiencies, although time of conception from surgery 
has no impact on neonatal or obstetric complications (230). Data shows no benefit with 
abortion rates. There is decreased rate of GDM after surgery although when compared to 
general population the rates are higher (231)(232). Data shows lower rates of pre 
ecclampsia in the postsurgical women(232). Studies donot show definite low risk for 
preterm birth. Observational studies have shown reduction in the mean birth weight after 
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surgery, though the rates of IUGR and SGA have been inconsistent (233). The caesarean 
rates are reportedly higher in post bariatric surgery patients (230). 
 
.  
INTERVENTION STRATEGIES 
Due to increasing burden of maternal obesity there is need for development of lifestyle 
modifications to improve the adverse pregnancy outcomes which include dietary 
modification. Increasing physical activity, limit development of insulin 
resistance(234)(235)(236)(237)(238)(239). Wolff et al showed thatdietary induced goal 
setting weight gain in obesity had lowering of fasting insulin levels. 
 
PREVENTION AND CONTROL 
Prevention and control should be started in childhood. It is harder to gain control in adults 
than children. The main components of weight reduction are : 
 
Dietary changes: 
Decrease in energy rich food 
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Increase fiber content 
Should be close to existing nutritional pattern 
Requires strong motivation 
 
COUNSELLING IN OBESITY 
1. Make a program including  
Diet 
Exercise 
Behaviour modification  
2. If possible pre pregnancy or in pregnancy 
3. Educate on possible complications due to obesity and also need for institutional 
care and closer surveillance. 
 
4. BMI should be calculated and allowed weight gain as per IOM 2009  should be 
explained. 
 
5. Nutrition consultation. 
 
6. Anesthesia consultation 
 
7. Thromboembolism risk assessment as per BMI. 
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MATERIALS AND METHODS 
 
It is a retrospective study comparing the rate of gestational hypertension in obese women 
with BMI > 35kg/m2 who had primary caesarean section with women who have normal 
BMI who had primary caesarean section. The BMI will be categorized using international 
classification of BMI. The 2 groups of women are with BMI > 35 kg/m2 who had 
primary caesarean and women with normal BMI 18.5 – 24.99 kg/m2 who had primary 
caesarean.The BMI will be calculated taking weight recorded when less than 16 weeks of 
gestation during antenatal checkup. Only those patients whose BMI was available in less 
than 16 weeks of gestational age were included in the study. The data was collected from 
the in-patient records of the patients admitted in CMC labor room for delivery in the time 
period of June 31
st
 2015 and June 31
st
 2013. The maternal outcomes of GDM, pre 
ecclampsia, preterm labor, chronic HTN, perineal injuries etc. and fetal outcomes of 
macrosomia, APGAR <7 at 5 minutes, IUGR, pre term birth, still birth etc.were 
compared. 
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Diagrammatic algorithm of study: 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From birth registry in labor room records, women with normal BMI 
who had primary CS and women with BMI>35 kg/m2 who had 
primary CS were found 
In-patient records of these patients were obtained and seen if  
maternal weight is available measured in < 16 weeks of 
gestational age. 
Height and weight measured in <16 
weeks gestational age available 
 
Height and weight not measured in <16 weeks 
gestational age not available 
Excluded from study 
Included in study 
Data collected on  
Primary LSCS rate and indications, Maternal outcomes, 
Fetal outcomes 
1. Rate of gestational hypertension in the 2 groups of women with BMI > 35 
kg/m2 who had primary LSCS and normal BMI who had primary LSCS  was 
compared. 
2. Maternal and fetal outcomes in these two groups were compared 
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Inclusion criteria: 
1. Patients delivered in CMC labor room for delivery in the time period of June 31st 
2015 and June 31
st
 2013. 
2. Height and weight recording done in < 16 weeks during antenatal checkup is 
available. 
3. BMI should belong to 18.5 to 24.99 kg/m2 in one group and > 35 kg/m2 in the 
other. 
 
SAMPLE SIZE CALCULATION 
Two Proportion - Hypothesis Testing - Large Proportion - Equal Allocation 
 
 Proportion of gestational hypertension in women with BMI>35 kg/m2 who had primary 
LSCS 0.27 
Proportion of gestational hypertension in women with normal BMI who had primary 
LSCS 0.1 
Estimated risk difference  0.17 
Power (1- beta) % 90 
Alpha error (%) 5 
1 or 2 sided  2 
Required sample size for each arm  108 
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Note: Using labor room database in CMC hospital Vellore, women with BMI>35 with 
gestational hypertension being 27% and in women with normal BMI with gestational 
hypertension being 10% with 90% power and 5% alpha value, 216 women (108 in each 
group) will be required for the study with BMI>35 and women with normal BMI who 
had primary LSCS 
  
 
DATA ANALYSIS PLAN: 
Data was summarized as mean and SD or median and range for normally and non-
normally distributed continuous variables, respectively. Categorical variables were 
presented as counts and percentages. Two sample t- test and chi-square test was used to 
test the mean difference and proportions between groups. 
 
IRB APPROVAL NUMBER:  IRB Min no: 9254 dated 12.01.2015. 
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RESULTS AND DISCUSSION 
Primary outcome: 
Gestational hypertension: 
 Gestational hypertension 
BMI Present  Absent  P value 
Normal BMI 4(5.5) 69 (94.5) >0.001 
BMI > 35 kg/m2     19 (41.3)      27 (58.7) 
*BMI –body mass index, in brackets is the percentage  
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Rate of gestational hypertension in women with normal BMI and BMI>35 kg/m2 
= 4/73 x 100 = 5.5 % 
Rate of gestational hypertension in women with BMI > 35 kg/m2 
= 19/46 x 100 = 41.3 % 
The rate of gestational hypertension is significantly higher in the group with BMI ≥ 35 
kg/m2 41.3% as compared to 5.5% in normal BMI group. 
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Secondary outcomes:                
 
Maternal outcomes:                                                         Fetal outcomes: 
Infertility                                                                            Macrosomia 
Previous abortions                                                              NICU admission 
GDM                                                                                  APGAR < 7 at 5 min of birth                                                                 
Pregestational diabetes 
Gestational hypertension 
Chronic hypertension 
Blood loss > 1 litre 
Postpartum fever 
Wound infection 
Duration of hospital stay 
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Demographic and clinical characteristics: 
 Normal BMI BMI≥ 35 P value 
Socio economic status 
             Low 
             Middle 
             High  
 
1(1.4) 
56 (80) 
13 (18.6) 
 
1 (2.27) 
37 (84.1) 
6 (13.6) 
 
0.756 
 
Age 
<20 years 
             20-29 years 
>30 years 
 
4 (5.5) 
50 (68.5) 
19 (26) 
 
1 (2.2) 
28 (60.9) 
17 (37) 
 
0.35 
Parity 
           Nulliparous 
           Parity 1 
           Parity ≥ 2 
 
59 (80.8) 
9 (12.3) 
5 (6.8) 
 
35 (76.1) 
9 (19.6) 
2 (4.3) 
0.507 
Average gestation at booking 10-11 weeks 10-11 weeks 0.649 
Average gestation at delivery 38-39 weeks 36-37 weeks 0.0016 
Previous abortions 10 (13.7) 13 (28.3) 0.05 
Infertility 6 (8.2) 15 (32.6) 0.001 
Gestational diabetes 13 (18.1) 18 (39.1) 0.01 
Pre gestational diabetes 2 (2.8) 2 (4.3) 0.646 
Chronic hypertension 0 10 (21.7) >0.001 
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Gestational hypertension 4 (5.5) 19 (41.3) >0.001 
Elective LSCS 13 (17.8) 6 (13.0) 0.490 
Emergency LSCS 60 (82.2) 40 (86.9) 0.490 
Blood loss ≥ 1 litre 4 (5.5) 2 (4.3) 0.89 
Postpartum fever 10 (13.7) 10 (13.0) 0.919 
Wound infection 1 (1.4) 3 (6.5) 0.129 
Baby requiring NICU admission 11 (15.1) 12 (26.1) 0.138 
Macrosomia 0 5 (10.9) 0.004 
APGAR < 7 at 5 min 4 (5.5) 1 (2.2) 0.381 
Average hospital stay 47 (64.4) 25 (54.3) 0.275 
 
Age: 
BMI Age in years 
 <20  20-29  >30 P value 
Normal BMI 4 (5.5) 50 (68.5) 19 (26.0) 0.35 
BMI > 35 kg/m2 1 (2.2) 28 (60.9) 17 (37) 
 
 N Mean SD Minimum Maximum  
Normal BMI 73 27.0 5.21 19 42 
BMI > 35 kg/m2 46 28.3 4.93 18 38 
SD-standard deviation 
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There is no difference in the percentage of women in the age group of more than 30 years 
in both the BMI groups. In both the BMI groups, majority of the women are in the age 
group of 20-29 yrs. 
 
Parity: 
 Parity  
BMI Nulliparous Para 1 Para ≥ 2 P value 
Normal BMI 59 (80.8) 9 (12.3) 5 (6.8) 0.507 
BMI > 35 kg/m2 35 (76.1) 9 (19.6) 2 (4.3) 
 
There is no difference in the percentage of nulliparous women in the two BMI groups. 
The percentage of women in both BMI groups is higher in the nulliparous group since the 
cohort is of women who underwent primary LSCS. 
 
Socio economic status: 
 Socio economic status : 
BMI Low  Middle  High  P value  
Normal BMI 1 (1.43%) 56 (80%) 13 (18.57%)  0.75 
BMI > 35 kg/m2 1 (2.27%) 37 (84.09%) 6 (13.64%) 
 
The data regarding BMI was not available for 5 patients. There is no difference in socio 
economic status of women in the two BMI groups. 
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History of previous abortion: 
 History of previous abortion  
BMI Present  Absent  P value 
Normal BMI 10 (13.7) 63 (86.3) 0.05 
BMI > 35 kg/m2 13 (28.3) 33 (71.7) 
 
 
 
 
There was a marginal difference in the number of women who had history of previous 
abortion which was 13.7 % in the normal BMI group and 28.3 % in the BMI > 35 kg/m2 
group. 
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History of previous Abortion
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Infertility: 
 Infertility   
BMI Present  Absent  P value 
Normal BMI 6 (8.2) 67 (91.8) 0.001 
BMI > 35 kg/m2 15 (32.6) 31 (67.4) 
 
 
 
 
In the normal BMI group 8.2% women had history of infertility whereas in the BMI > 35 
kg/m2  group, 15 % of women have history of infertility which is nearly double than the 
number of women of the normal BMI group. 
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Gestational diabetes : 
 Gestational diabetes  
BMI Present  Absent  P value 
Normal BMI 13 (18.1) 59(81.9) 0.011 
BMI > 35 kg/m2 18 (39.1) 28 (60.9) 
 
 
 
Total number of women = 118 since Glucose tolerance test or AC / PC not tested in one 
patient. GDM is higher 39.1% in the BMI >35 kg/m2 group where as it is only 18.1% in 
the normal BMI group. 
 
 
 
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
45.00%
Normal BMI BMI>35kg/m2
Gestational Diabetes
Gestational Diabetes
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Age, BMI and GDM: 
Age  Normal BMI  
GDM 
Normal BMI  
No GDM 
BMI>35  
GDM 
BMI>35  
No GDM 
<20 years 0 4 (6.8) 0 1 (3.6) 
20-29 years 8 (61.5) 41 (69.5) 14 (77.8) 14 (50.0) 
>30 years 5 (38.5) 14 (23.7) 4 (22.2) 13 (46.4) 
 
There is no rise in the percentage of women with age above 30 years in both the BMI 
categories. This may be because of the majority of women being in the 20-29 year age 
group. 
 
 
Pre gestational diabetes : 
 Pre gestational diabetes  
BMI Present  Absent  P value 
Normal BMI 2 (2.8) 70 (97.2) 0.646 
BMI > 35 kg/m2 2 (4.3) 44 (95.6) 
 
Total number of women = 118 since Glucose tolerance test or AC / PC not tested in one 
patient. There is no significant difference in the percentage of pre gestational diabetic 
women in both the BMI groups. 
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Hypertension  
 Hypertension  
BMI Present  Absent  P value 
Normal BMI 4 (5.5) 69(94.5) >0.001 
BMI ≥ 35 kg/m2 29 (63.0) 17 (37) 
 
 
 Hypertension No hypertension  
BMI Gestational Chronic   P value 
Normal BMI 4 (5.5) 0 69 (94.5) >0.001 
BMI > 35 kg/m2 19 (41.3) 10 (21.7) 17 (37) 
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The rate of gestational hypertension is 5.5% in the normal BMI group whereas it is 
41.3% in the group with BMI > 35 kg/m2. There were 10 patients, 21.7% with chronic 
hypertension and all of them belonged to the BMI >35 category. 
 
Gestational hypertension-GHTN 
 GHTN  
 
Mild 
PE 
Severe PE Ecclampsia P value 
Normal BMI 1 (25) 0 2 (50) 1 (25) 0.211 
BMI > 35 kg/m2 15 (79) 0 4 (21) 0 
PE- pre ecclampsia 
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10.00%
20.00%
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In the normal BMI group 2 patients had severe pre ecclampsia and one patient had 
ecclampsia.  In the BMI > 35 category, 15 (79%) of 19 patients had gestational 
hypertension without pre ecclampsia and 4 (21%) developed severe pre ecclampsia. The 
numbers are small to commit on significance. 
 GHTN on 
monitoring 
 
GHTN on 
medication 
Not 
applicable 
P value 
Normal BMI 1 (25) 2 (50) 1(25) 0.211 
BMI > 35 kg/2 14 (68.4) 5(26.3) 1(5.3) 
 
In the patients with BMI > 35 kg/m2, 14 (68.4 %) were only on ambulatory BP 
monitoring, 5 (26.3%) required medications, one patient was admitted with severe pre 
ecclampsia. There was no significant difference when the 2 BMI groups were compared. 
71%
21%
Gestational Hypertension in BMI>35Kg/m2
GHTN without PE Severe  pre ecclampsia
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Chronic hypertension and cause: 
Chronic hypertension cause 
 Essential  Renal 
BMI > 35 kg/m2 10 1 
 
Of the 11 patients with chronic hypertension, the cause for 10 patients (90.9%) was 
essential hypertension, 1patient (9.1%) had renal pathology. 
Indication for LSCS 
 Indication for LSCS 
BMI Elective  Emergency  P value 
Normal BMI 13 (17.8) 60 (82.2) 0.49 
BMI > 35 kg/m2 6 (13.0) 40 (86.9) 
 
The percentage of women who were taken for elective and emergency caesarean section 
is similar in both the BMI groups. The various indications are tabulated in the table 
below. The others in this grouping include IVF pregnancy, elderly gravida, cord 
presentation, big baby, seropositivity, placenta previa, abnormal Doppler, abruption etc. 
The numbers are individually small for analyzing separately. 
 
 Indication for LSCS 
 NRFS Malpresentation Dysfunctional 
labour 
Failed 
induction 
Others  P value 
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Normal BMI 29  
(39.7) 
17 
 (23.3) 
10  
(13.7) 
7 
 (9.6) 
10  
(13.7) 
0.078 
BMI >35 
kg/m2 
14  
(30.4) 
5  
(10.9) 
5 
 (10.9) 
9  
(19.6) 
13 
 (28.3) 
NRFS-non-reassuring fetal status 
There is no significant difference in the percentage of indications of NRFS, dysfunctional 
labor, failed induction in the two BMI categories. 
Total blood loss  
 Total blood loss 
BMI 500 ml ≥ 500ml -1L 1L P value 
Normal BMI 34 (46.6) 35 (47.9) 4 (5.5) 0.89 
BMI > 35 kg/m2 20 (43.5) 24 (52.2) 2 (4.3) 
 
There is no difference in major blood loss or blood loss more than 1L in the two BMI 
categories, but the numbers are very small. 
Postpartum fever 
 Postpartum fever  
BMI Present  Absent  P value 
Normal BMI 10 (13.7) 63 (86.3) 0.919 
BMI >35 kg/m2 6 (13.0) 40 (87) 
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There is no significant difference in the percentage of women who had postpartum fever 
among the two BMI categories. 
Indication for induction of labor: 
 Past 
dates 
Decreased 
AFI 
Pre 
ecclampsia 
PROM/ 
PPROM 
IUGR Others  P 
value 
Normal 
BMI 
12 
(16.4) 
1 (1.4) 2(2.7) 13(17.8) 11(15.1) 34 (46.6) 0.03 
BMI > 
35 
4 (9.1) 3 (6.8) 2 (4.5) 1 (2.3) 4 (9.1) 30(68.2) 
 
The number of patients induced for past dates was higher among the women with normal 
BMI 16.4% compared to 9.1% in the group with BMI > 35 kg/m2. The PROM/ PPROM 
rates were also higher in the normal BMI group 17.8% compared to 2.35% in higher BMI 
group. IUGR requiring induction of labor was higher in the normal BMI category 15.1% 
compared to 9.1 % in the BMI ≥ 35 kg/m2 category. The others categorised is a sum of 
all patients who were not induced, 5 patients with high BP, 4 patients were induced since 
they were on oral hypoglycemic agents and insulin, 2 for GDM and 3 for infertility. The 
numbers are small for comparison. 
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Postpartum antibiotics 
Postpartum antibiotics P value 
BMI required Not required 
Normal BMI 15 (20.5) 58 (79.4) 0.482 
BMI > 35 kg/m2 12 (26.1) 34 (73.9) 
 
The usage of postpartum antibiotics in the two BMI groups was not found to be 
significantly different. The indication for postpartum antibiotics were also nearly equally 
distributed. 
Duration of antibiotics: 
 N P50 minimum Maximum 
Normal BMI 15 3.0 2 19 
BMI > 35 12 4.5 1 7 
 
 The mean number of days of antibiotic duration was 4.5 days in BMI > 35 category 
compared to 3.0 days in normal BMI category. One patient with blood culture positive 
sepsis was on a total duration of 19 days in the normal BMI category. 
Gestational age at delivery: 
 N Mean  SD 
Normal BMI  73 38.34 1.93 
BMI > 35  46 36.97 2.68 
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SD = standard deviation 
The mean gestational age of delivery in the normal BMI group was 38.34 weeks 
compared to 36.97 in the BMI > 35 kg/m2 group which is marginally preterm in 
comparison but not statistically significant. 
Wound infection: 
Wound infection  
BMI Present  Absent  P value 
Normal BMI 1 (1.4) 72 (98.6) 0.129 
BMI > 35 kg/m2 3 (6.5) 43 (93.5) 
 
In this study there was no difference in wound infection rates in the two BMI groups. 
Since it is a retrospective study and there was no follow up done after delivery, the 
women who would have been treated in nearby hospitals after discharge are likely to be 
missed out. 
Multiple gestation: 
 Multiple pregnancy  
BMI Singleton Twin pregnancy P value 
Normal BMI 67 (91.8) 6 (8.2) 0.733 
BMI > 35 kg/m2 43 (93.5) 3 (6.5) 
 
There was no difference in the twin rates of both BMI groups requiring primary LSCS. 
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Average hospital stay: 
Average hospital stay  
 3-6 days ≥ 7 days P value 
Normal BMI 47 (64.4) 26 (35.6) 0.275 
BMI > 35 kg/m2 25(54.4) 21 (45.6) 
 
There was no significant difference in the duration of hospital stay in the 2 BMI 
categories. 
 
Macrosomia: 
 Macrosomia :birth weight > 4 kg  
BMI <4 kg ≥ 4 kg P value 
Normal BMI 73 (100) 0 0.004 
BMI >35 kg/m2 41 (89.1) 5 (10.9) 
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There were 5 (10.9%) patients with birth weight of babies being more than 4 kg. All the 5 
patients were in the category of BM I≥ 35 kg/m2. There was no baby with macrosomia in 
the normal BMI category. 
 
NICU admission: 
 NICU admission  
BMI Present  Absent  P value 
Normal BMI 11 (15.0) 62 (84.9) 0.138 
BMI > 35 kg/m2 12 (26.1) 34 (73.9) 
 
The NICU admission rates were slightly higher in the BMI > 35 category 26.1% 
compared to 15% in the normal BMI category. P value however is not significant. 
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APGAR < 7 at 5 min: 
 
 APGAR < 7 at 5 min  
BMI Present  Absent  P value 
Normal BMI 4 (5.5) 69 (94.5) 0.381 
BMI > 35 kg/m2 1 (2.2) 45 (97.8) 
 
APGAR at 5 minutes of birth is not significantly lower  in either of the BMI groups. 
 
 
Onset of labour- spontaneous or induction of labour 
Spontaneous onset or induction of labor 
 spontaneous Induction 
of labour 
Not applicable P value 
Normal BMI 10 (13.7) 43 (58.9) 20 (27.4) 0.335 
BMI > 35 kg/m2 3 (6.5) 26 (56.5) 17 (37) 
 
Percentage of women induced in the normal BMI category = 43/73 =58.9% 
Percentage of women induced in the category of BMI > 35kg/m2 = 26/46 =56.5% 
The percentage of women in both categories is comparable. 
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Among the women who had failed induction: 
 
 Spontaneous  
labour 
Induction of 
labour 
NA  
P value 
Normal BMI 0 7 (16.3) 3 (7)  
>0.001 BMI >35 kg/m2 0 9 (34.6) 0 
 
In normal BMI = 7/43= 16.3% 
In BMI > 35 kg/m2 = 9/26 = 34.6 % 
Thus the rate of failed induction is nearly double in the BMI > 35 kg/m2 category which 
is statistically significant. Thus the population for induction of labor should be carefully 
selected to decrease the rate of primary caesarean. 
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DISCUSSION 
Gestational hypertension is a hypertensive disorder of pregnancy where the implication 
on baby and mother is unknown. The significance of gestational hypertension without 
changes of pre ecclampsia unlike pre ecclampsia is not established.  
Increased caesarean section rate is well known among obese women (119)(117). 
Iatrogenic intervention with gestational hypertension without pre ecclampsia could be a 
reason contributing to increased caesarean section rate. 
In our small study which is not adequately powered, the percentage of gestational 
hypertension among hypertensive disorders of pregnancy is much higher in the obese 
women with BMI > 35 kg/m2 when compared with women of normal BMI. This 
emphasizes the need for accurate BP reading using appropriate cuff size, which is usually 
not done in most of the facilities providing antenatal care.  
The aim of this observational cohort study is to assess the rate of gestational hypertension 
in the two groups of BMI: Normal 18.5-24.99kg/m2 and BMI>35 Kg/m2. 
The secondary outcomes studied were maternal outcomes of infertility, previous abortion 
,GDM, pre gestational diabetes, gestational hypertension, chronic hypertension, blood 
loss >1 liter, postpartum fever, wound infection and duration of hospital stay. The fetal 
outcomes compared are macrosomia, NICU admission and APGAR <7 at five minutes of 
birth. In this study the mean age of the patients was 27 years in normal BMI category and 
28 years in BMI>35 Kg/m2 category. The mean gestational age at booking was 10 to 11 
weeks in both the groups. The base line characteristics had no significant difference in 
the two groups. The mean gestational age at delivery was 38.3 weeks in normal BMI 
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group and 36.97 weeks in BMI>35 Kg/m2 category, but the difference was not 
statistically significant. 
The rate of previous abortion was 13.7 in normal BMI group and 28.3 inin BMI> 35 
kg/m2 category which was marginally higher. 8.2% of women in normal BMI group had 
history of infertility compared to 15% in thein BMI>35 Kg/m2 category. 
18.1 % of women in normal BMI group had gestational diabetes compared to 39.1% 
women in thein BMI >35 kg/m2 category. 
On comparing the age and BMI, there was no rise in the percentage of gestational 
diabetes in the age group above 30 years. There was no difference in the rate of pre 
gestational diabetic women in the 2 BMI categories. 
The rate of hypertension was significantly higher 63% in the category of in BMI>35 
kg/m2,compared to 5.5 % in women with normal BMI. 
On subdividing into gestational and chronic hypertension, the rates were higher in both 
the categories. The rate of gestational hypertension was 5.5% in the group with normal 
BMI and 41.3% in the group with BMI >35 kg/m2. Chronic hypertension was nil in the 
normal BMI group and 21.7 % in the group with BMI > 35 kg/m2.  Gestational 
hypertensionwithout pre ecclampsia was 79% in the women with BMI > 35 kg/m2  and 
21% of women had severe pre ecclampsia. The cause for chronic hypertension was 
essential hypertension in 90.9% cases and renal pathology in 9.1% cases.  
There was no significant difference in the rate of elective or emergency caesarean in both 
the BMI categories. There was no significant difference in the rates of dysfunctional 
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labor, failed induction or caesarean for non-reassuring fetal status in both the BMI 
categories. 
There was no difference in the rates of postpartum hemorrhage in both the categories. 
The number of patients induced for past dates was higher, 16.4% among women with 
normal BMI compared to 9.1% in women with BMI ≥ 35 kg/m2. The rates of 
PROM/PPROM were also higher in the normal BMI group15.1% compared to 9.1 % in 
the group with BMI > 35 kg/m2. 
There was no difference in the requirement of postpartum antibiotics and postpartum 
fever. The mean duration of antibiotic usage was slightly higher in the group with BMI > 
35 kg/m2, 4.5 days compared to 3 days in the normal BMI group. The difference was 
however not significant. 
Duration of average hospital stay was similar in both the BMI groups. There was no baby 
with macrosomia in the normal BMI category compared to 10.9% in group with BMI > 
35 kg/m2. 
The rated of admissions to NICU and APGAR < 7 at 5 minutes of birth were not 
significantly different in both the BMI groups. 
The rate of failed induction was 16.3% in the normal BMI group and 34.6 % in the group 
with BMI > 35 kgm2 which is nearly double. 
The sample size being small and that the sample size required could not be completed, is 
a major drawback in establishing significance of various variables in this study. 
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LIMITATIONS: 
1. The study was retrospective 
2. This study is in tertiary care center and the complications may not represent same 
rate as in general population. 
3. No blinding. 
4. No long term follow up. 
5. The sample size could not be reached due to lack of time. 
 
CONCLUSION 
The study did not complete the required sample size. The study found significant higher 
rate of gestational and chronic hypertension in the group of women with BMI ≥ 35 kg/m2 
compared to women with normal BMI. There was no macrosomia among women with 
normal BMI and 10.9% in women with BMI ≥ 35 kg/m2. The rate of gestational diabetes 
was 39% inwomen with BMI ≥ 35 kg/m2 and 18% in women with normal BMI. The rate 
of infertility and previous abortion is significantly higher in women with BMI ≥ 35 
kg/m2. The other maternal outcomes of pre gestational diabetes, postpartum hemorrhage, 
postpartum fever, postpartum antibiotic usage, wound infection and duration of hospital 
stay were not significantly in the 2 BMI groups. The fetal outcomes of NICU admission 
and APGAR < 7 at 5 minutes of birth were comparable in both the groups. The rate of 
failed induction is almost double 34.6% in the BMI > 35kg/m2 group compared to the 
normal BMI group which was 16.3%. 
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ABBREVIATIONS 
 
 
Ht- height 
Wt- weight 
Cms- centimeters 
GDM- gestational diabetes mellitus 
GHTN- gestational hypertension 
HTN- hypertension 
IL- interleukins 
TNF- tumor necrosis factor 
BMI- body mass index 
BP- blood pressure 
Kgs- kilograms 
VTE-venous thromboembolism 
LMWH- low molecular weight heparin 
DVT- deep venous thrombosis 
CUS- compression ultrasound 
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ANNEXTURE I -TABLES: 
TABLE 1:Five definitions of the metabolic syndrome 
 
 
NCEP: National Cholesterol Education Program; IDF: International Diabetes Federation; 
EGIR: Group for the Study of Insulin Resistance; WHO: World Health Organization; 
AACE: American Association of Clinical Endocrinologists; HDL: high density 
lipoprotein; BMI: body mass index. 
* Most commonly agreed upon criteria for metabolic syndrome (any three of five risk 
factors). 
• For South Asia and Chinese patients, waist ≥90 cm (men) or ≥80 cm (women); for 
Japanese patients, waist ≥90 cm (men) or ≥80 cm (women). 
Δ Insulin resistance measured using insulin clamp. 
◊ High risk of being insulin resistant is indicated by the presence of at least one of the 
following: diagnosis of CVD, hypertension, polycystic ovary syndrome, non-alcoholic 
123 
 
fatty liver disease or acanthosis nigricans; family history of type 2 diabetes, hypertension 
of CVD; history of gestational diabetes or glucose intolerance; nonwhite ethnicity; 
sedentary lifestyle; BMI 25 kb/m
2
 or waist circumference 94 cm for men and 80 cm for 
women; and age 40 years. 
§ Treatment with one or more of fibrates or niacin. 
≦ In Asian patients, waist ≥90 cm (men) or ≥80 cm (women) 
 
TABLE 2: 
 
presence of any three of the following five traits: 
Abdominal obesity, defined as a waist circumference in men ≥102 cm (40 in) and in women ≥88 cm (35 
in) 
Serum triglycerides ≥150 mg/dL (1.7 mmol/L) or drug treatment for elevated triglycerides 
 
Serum high-density lipoprotein (HDL) cholesterol <40 mg/dL (1 mmol/L) in men and 
<50 mg/dL (1.3 mmol/L) in women or drug treatment for low HDL cholesterol 
Blood pressure ≥130/85 mmHg or drug treatment for elevated blood pressure 
 
Fasting plasma glucose (FPG) ≥100 mg/dL (5.6 mmol/L) or drug treatment for elevated blood glucose 
 
 
 
 
 
 
TABLE 3: 
Definitions of sepsis 
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TABLE 4 : The Alexis O C-section retractor 
 
Usage  provides 360 degrees of circumferential 
atraumatic retraction and protection during 
Cesarean section 
Made of single-use device that consists of a flexible 
polymer membrane  
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TABLE 5: Risk factors for VTE in pregnancy and peuperium 
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